[Combined vaccine against hepatitis A and B].
Among the infectious virus hepatitis diseases, types A and B can be successfully prevented with vaccinations. WHO recommend effective control of hepatitis A through immunisation, especially among populations with indirect or high endemicity. Since 1991 WHO has been recommending vaccinations against hepatitis B. It is planned to introduce it in all countries by the year 2007. Vaccinations against hepatitis A & B are recommended for people travelling to the regions endemic for these infections or for those with high professional risk of HAV and HBV. Presented here are the characteristic features of the vaccine, the analysis concerning the evaluation of its effectiveness, comparison of this effectiveness with monovalent vaccine effectiveness, as well as evaluation of the tolerance and safety.
Pawłowska
Małgorzata
M
Katedra i Klinika Chorób Zakaźnych i Hepatologii Akademii Medycznej im LRydygiera w Bydgoszczy.
Halota
Waldemar
W
Kozielewicz
Dorota
D
D019353:Endemic Diseases / Q000517:prevention & control; D014943:Global Health; D006506:Hepatitis A / Q000517:prevention & control*; D022362:Hepatitis A Vaccines / Q000627:therapeutic use*; D006509:Hepatitis B / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000627:therapeutic use*; D006801:Humans; D032541:Mass Vaccination / Q000592:standards; D014195:Travel; D017778:Vaccines, Combined / Q000627:therapeutic use*
D022362:Hepatitis A Vaccines; D017325:Hepatitis B Vaccines; D017778:Vaccines, Combined